TWIGGE GIOVANI 4

Accession 0001567619-21-014513

CIK 0000874716other

View on SEC.gov Company Profile

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 5:02 PM ET

Size

30.6 KB

Accession

0001567619-21-014513

Insider Transaction Report

Form 4

Period: 2021-08-03

IDEXX LABORATORIES INC /DEIDXX

TWIGGE GIOVANI

CORPORATE VICE PRESIDENT

Transactions

Exercise/Conversion
Common Stock
2021-08-03$67.85/sh+1,476$100,147→ 18,447.478 total
Sale
Common Stock
2021-08-04$700.00/sh−1,319$923,300→ 27,230.478 total
Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2021-08-04−3,068→ 4,118 total
Exercise: $206.94Exp: 2029-02-13→ Common Stock (3,068 underlying)
Exercise/Conversion
Common Stock
2021-08-03$141.60/sh+8,874$1,256,558→ 27,321.478 total
Sale
Common Stock
2021-08-03$696.32/sh−1,838$1,279,837→ 18,447.478 total
Exercise/Conversion
Common Stock
2021-08-04$288.78/sh+1,893$546,661→ 28,549.478 total
Exercise/Conversion
Incentive Stock Option (right-to-buy)
2021-08-03−1,476→ 0 total
Exercise: $67.85Exp: 2026-02-13→ Common Stock (1,476 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2021-08-03−8,874→ 1,512 total
Exercise: $141.60Exp: 2027-02-13→ Common Stock (8,874 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2021-08-04−5,141→ 2,866 total
Exercise: $178.26Exp: 2028-02-13→ Common Stock (5,141 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2021-08-04−1,893→ 5,677 total
Exercise: $288.78Exp: 2030-02-13→ Common Stock (1,893 underlying)
Sale
Common Stock
2021-08-03$695.34/sh−7,036$4,892,395→ 20,285.478 total
Exercise/Conversion
Common Stock
2021-08-04$178.26/sh+5,141$916,435→ 23,588.478 total
Exercise/Conversion
Common Stock
2021-08-04$206.94/sh+3,068$634,892→ 26,656.478 total
Sale
Common Stock
2021-08-04$700.30/sh−9,242$6,472,198→ 17,988.478 total
Sale
Common Stock
2021-08-04$701.36/sh−860$603,170→ 17,128.478 total

Footnotes (11)

[F1]Includes a total of 21.4780 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
[F10]Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.
[F11]Not applicable.
[F2]Represents the weighted average price of the shares sold ranging from a low of $695.00 to a high of $695.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
[F3]Represents the weighted average price of the shares sold ranging from a low of $696.02 to a high of $696.78 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
[F4]Represents the weighted average price of the shares sold ranging from a low of $700.00 to a high of $700.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
[F5]Represents the weighted average price of the shares sold ranging from a low of $701.05 to a high of $701.91 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
[F6]Grant of option to buy 1,476 shares of Issuer common stock that vested as to 1 share on February 14, 2017, February 14, 2018 and February 14, 2020, respectively, and as to the remainder on February 14, 2021.
[F7]Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018.
[F8]Grant of option to buy 8,007 shares of Issuer common stock that vest in five annual installments beginning February 14, 2019.
[F9]Grant of option to buy 7,186 shares of Issuer common stock that vest in four annual installments beginning February 14, 2020.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

→

Entity typeother

Related Parties

filerCIK 0001500399

Filing Metadata

Form type: 4
Filed: Aug 4, 8:00 PM ET
Accepted: Aug 5, 5:02 PM ET
Size: 30.6 KB

View on SEC.gov